glp 1 medication south africa WHO backs GLP-1 drugs for long-term obesity treatment SAHPRA warns the public about

A study by Kromann et al

Novo Nordisk has confirmed that production has stabilized, allowing the company to meet current and future demand in the U.S

Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively

Our team of licensed professionals will review your information and provide approval in no time

CMS recently posted "Medicare GLP-1 Bridge Information for Pharmacists." It lists seven steps for filling prescriptions through the Bridge, beginning July 1